The risk of oesophageal adenocarcinoma after gastrectomy for peptic ulcer disease

https://doi.org/10.1016/j.ejca.2011.09.013Get rights and content

Abstract

Background

The influence of bile reflux in the development of oesophageal adenocarcinoma remains controversial. This was tested in a cohort of patients who had undergone gastrectomy, a procedure often entailed by substantial bile reflux.

Methods

A population-based cohort study of patients who had undergone gastrectomy for peptic ulcer disease in 1964–2008 in Sweden. Follow-up for cancer and censoring for death were achieved through linkages to nationwide registries of Cancer and Population, respectively. The number of observed cancer cases in the gastrectomy cohort was divided by the expected number, calculated from the incidence of the entire Swedish population of corresponding age, sex and calendar year. Relative risks were thus presented as standardised incidence ratios with 95% confidence intervals.

Results

After exclusion of all person-years the first year after surgery, the final gastrectomy cohort comprised of 19,767 patients. These patients were followed up for a median of 17 years, and contributed with a total of 348,231 person-years at risk. The observed number of patients with oesophageal adenocarcinoma (n = 7) was not higher than the expected (n = 11.6), providing a standardised incidence ratio of 0.6 (95% CI 0.2–1.2). There were no clear differences between sexes, age groups or latency intervals after gastrectomy.

Conclusions

Gastrectomy for peptic ulcer disease does not appear to increase the risk of oesophageal adenocarcinoma.

Introduction

Oesophageal adenocarcinoma is characterised by a poor prognosis and a rapidly increasing incidence during the last few decades,1, 2 patterns that stress the need for aetiological research. Gastro-oesophageal reflux, causing the premalignant epithelial metaplasia Barrett’s oesophagus, is the main risk factor for this tumour.3 Animal studies have indicated that duodeno-gastro-oesophageal reflux, with high contents of bile in the oesophagus, is an especially harmful component of reflux in the development of oesophageal adenocarcinoma,4, 5, 6, 7 and mechanisms explaining the carcinogenic effects of bile are being explored.7, 8, 9 The association between bile reflux and oesophageal adenocarcinoma in humans has, however, not been established. The slightly increased risk of oesophageal adenocarcinoma reported after cholecystectomy might be caused by an increased presence of bile in the oesophagus,10 but the average oesophageal bile exposure after cholecystectomy is low. The situation that occurs after partial or total gastrectomy mimics a human experimental model of bile reflux, since such surgery is often followed by a substantially increased risk of oesophageal exposure to bile.11, 12, 13, 14, 15, 16, 17, 18, 19 The anatomical rearrangement after gastrectomy means that duodenal contents easily flow back and reach the oesophagus. Data from a case series have suggested an increased risk of oesophageal adenocarcinoma after such surgery.20 Problems with evaluating risk of oesophageal adenocarcinoma after gastrectomy include the limited number of patients currently treated with such surgery, the need for a long follow-up time to assess cancer risk, and the low incidence of oesophageal adenocarcinoma. In Sweden, there are excellent opportunities for research based on nationwide and complete health care registries with a long history. These sources were utilised to conduct a cohort study assessing the relation between gastrectomy for peptic ulcer disease and risk of developing oesophageal adenocarcinoma.

Section snippets

Study design

This was a Swedish population-based cohort study, addressing the risk of developing oesophageal adenocarcinoma after gastrectomy, using the entire Swedish population during the study period 1964 through 2008 as database. The study cohort consisted of all patients who had undergone gastrectomy for a peptic ulcer disease during the study period, as recorded in the Swedish Patient Registry. Since there has been no private in-hospital care for patients undergoing gastrectomy in Sweden and patients

Results

The gastrectomy cohort included 19,767 patients. Some characteristics of this cohort are presented in Table 1. The cohort members were followed up for a median of 17 years, and the total number of person-years at risk was 348,231. The study cohort consisted of more men (62.3%) than women. The vast majority of operations were partial gastrectomies (96.4%), while the remaining part was total gastrectomies.

The observed number of patients who developed oesophageal adenocarcinoma during follow-up was

Discussion

This study does not provide any evidence in support of the hypothesis that gastrectomy increases the risk of oesophageal adenocarcinoma.

Advantages of the study include the population-based cohort design, the complete assessment of both the exposure and the outcome, and the long follow-up period. The use of a gastrectomy cohort could be regarded as a human experiment model that allows assessment of effects of the exposure to bile reflux. A limitation is the low number of incident patients

Author contribution

Jesper Lagergren was responsible for the study concept and design, acquisition and interpretation of data, drafting of the manuscript. Anna Lindam was responsible for the statistical analysis, and provided critical revision of the manuscript.

Responsibility statement

The corresponding author had full access to all of the data and takes full responsibility for the veracity of the data and statistical analysis.

Conflict of interest statement

None declared.

Acknowledgements

The study was supported by project grants from the Swedish Research Council (SIMSAM) and the Swedish Cancer Society. These fund givers had no influence on the contents of the paper.

References (28)

  • M. Fein et al.

    Carcinogenesis in reflux disease – in search for bile-specific effects

    Microsurgery

    (2007)
  • J. Hong et al.

    Bile acid reflux contributes to development of esophageal adenocarcinoma via activation of phosphatidylinositol-specific phospholipase Cgamma2 and NADPH oxidase NOX5-S

    Cancer Res

    (2010)
  • R.F. Souza et al.

    Acid, bile, and CDX: the ABCs of making Barrett’s metaplasia

    Am J Physiol Gastrointest Liver Physiol

    (2008)
  • J.L. Herrington et al.

    Surgical management of reflux gastritis

    Ann Surg

    (1974)
  • Cited by (4)

    • A Tool to Predict Risk for Gastric Cancer in Patients With Peptic Ulcer Disease on the Basis of a Nationwide Cohort

      2015, Clinical Gastroenterology and Hepatology
      Citation Excerpt :

      On the other hand, routine surveillance endoscopy without consideration of other risk factors is unjustified. Gastrectomy is also a risk factor of gastric cancer, and the risk might be increased decades after partial gastrectomy.29,30 The carcinogenesis could be different among patients who underwent gastrectomy, and the cancer risk should be evaluated separately.

    View full text